|
Neoplasia
Citations 301-310 of 4217 total displayed.
|
Past content
(since Jan 1997):
|
EBV LMP2A affects LMP1-mediated NF- B signaling and survival of lymphoma cells by regulating TRAF2 expression
- Ilaria Guasparri, Darya Bubman, and Ethel Cesarman
Blood 2008; 111: 3813-3820.
[Abstract]
[Full text]
[PDF]
Lyn regulates BCR-ABL and Gab2 tyrosine phosphorylation and c-Cbl protein stability in imatinib-resistant chronic myelogenous leukemia cells
- Ji Wu, Feng Meng, Henry Lu, Ling Kong, William Bornmann, Zhenghong Peng, Moshe Talpaz, and Nicholas J. Donato
Blood 2008; 111: 3821-3829.
[Abstract]
[Full text]
[PDF]
Human antibody RNase fusion protein targeting CD30+ lymphomas
- Christian Menzel, Thomas Schirrmann, Zoltan Konthur, Thomas Jostock, and Stefan Dübel
Blood 2008; 111: 3830-3837.
[Abstract]
[Full text]
[PDF]
A new perspective: molecular motifs on oxidized LDL, apoptotic cells, and bacteria are targets for chronic lymphocytic leukemia antibodies
- Anna Lanemo Myhrinder, Eva Hellqvist, Ekaterina Sidorova, Anita Söderberg, Helen Baxendale, Charlotte Dahle, Kerstin Willander, Gerard Tobin, Eva Bäckman, Ola Söderberg, Richard Rosenquist, Sohvi Hörkkö, and Anders Rosén
Blood 2008; 111: 3838-3848.
[Abstract]
[Full text]
[PDF]
Knock-in of an internal tandem duplication mutation into murine FLT3 confers myeloproliferative disease in a mouse model
- Li Li, Obdulio Piloto, Ho Bao Nguyen, Kathleen Greenberg, Kogo Takamiya, Frederick Racke, David Huso, and Donald Small
Blood 2008; 111: 3849-3858.
[Abstract]
[Full text]
[PDF]
Npm1 is a haploinsufficient suppressor of myeloid and lymphoid malignancies in the mouse
- Paolo Sportoletti, Silvia Grisendi, Samia M. Majid, Ke Cheng, John G. Clohessy, Agnes Viale, Julie Teruya-Feldstein, and Pier Paolo Pandolfi
Blood 2008; 111: 3859-3862.
[Abstract]
[Full text]
[PDF]
Clonal heterogeneity in polycythemia vera patients with JAK2 exon12 and JAK2-V617F mutations
- Sai Li, Robert Kralovics, Gennaro De Libero, Alexandre Theocharides, Heinz Gisslinger, and Radek C. Skoda
Blood 2008; 111: 3863-3866.
[Abstract]
[Full text]
[PDF]
PRDM1 is involved in chemoresistance of T-cell lymphoma and down-regulated by the proteasome inhibitor
- Wei-Li Zhao, Yan-Yan Liu, Qun-Ling Zhang, Li Wang, Christophe Leboeuf, Yi-Wen Zhang, Jie Ma, José-Francisco Garcia, Yong-Ping Song, Jun-Min Li, Zhi-Xiang Shen, Zhu Chen, Anne Janin, and Sai-Juan Chen
Blood 2008; 111: 3867-3871.
[Abstract]
[Full text]
[PDF]
Bortezomib inhibits tumor adaptation to hypoxia by stimulating the FIH-mediated repression of hypoxia-inducible factor-1
- Dong Hoon Shin, Yang-Sook Chun, Dong Soon Lee, L. Eric Huang, and Jong-Wan Park
Blood 2008; 111: 3131-3136.
[Abstract]
[Full text]
[PDF]
Nonstochastic pairing of immunoglobulin heavy and light chains expressed by chronic lymphocytic leukemia B cells is predicated on the heavy chain CDR3
- George F. Widhopf, II, Craig J. Goldberg, Traci L. Toy, Laura Z. Rassenti, William G. Wierda, John C. Byrd, Michael J. Keating, John G. Gribben, Kanti R. Rai, and Thomas J. Kipps
Blood 2008; 111: 3137-3144.
[Abstract]
[Full text]
[PDF]
|
|
